SEARCH RESULTS

9 RESULTS

Eric Siemers on Biogen/Eisai Halt Phase 3 Aducanumab Trials

COMMENT Alzheimer’s patients and their families suffered yet another blow when Biogen announced that the EMERGE and ENGAGE Phase 3 trials of aducanumab were being stopped for futility. A more complete understanding of the potential causes of yet another negative ...

Eric Siemers on A Blood Test for AD?

COMMENT Wyss-Coray et al. report an investigational diagnostic test for AD that could represent a major advance for the field if their results can be replicated. A method of improving the diagnostic accuracy of AD would be valuable immediately to ensure that ...

Current Filters

  • TYPE: Comment x
  • Commentator: Siemers, Eric x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE